Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAP2K1 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
mRNA | RNASE6 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | RIMKLA | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | NPIPA1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | TRIM9 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MAP1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |